Gilead Sciences reported additional data on investigational antiviral remdesivir for treatment of COVID-19
On Jul. 10, 2020, Gilead Sciences announced that a comparative analysis of the Phase 3 SIMPLE-Severe trial and…
On Jul. 10, 2020, Gilead Sciences announced that a comparative analysis of the Phase 3 SIMPLE-Severe trial and…
On Jul. 10, 2020, the Imaging Platform at the Broad Institute of MIT and Harvard, together with industry…
On Jul. 10, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced that they will…
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…
On Jul. 9, 2020, a study, published in the journal Cell Systems, laid out a new framework for…
On Jul. 9, 2020, the CDC reported that after a decade of increasing rates, contact sportsヨrelated TBI ED…
On Jul. 9, 2020, WHO announced the initiation of the Independent Panel for Pandemic Preparedness and Response (IPPR)…
On Jul. 9, 2020, Atos announced that the Biocomputing Unit at the Spanish National Center for Biotechnology (CNB),…
On Jul. 9, 2020, Royal Philips announced it had formed a strategic collaboration with BioIntelliSense, a continuous health…
On Jul. 9, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced that it is partnering with Albany…
On Jul. 9, 2020 Moderna and Laboratorios Farmaceuticos Rovi announced a collaboration for large-scale, commercial fill-finish manufacturing of…
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
On Jul. 9, 2020, Pfizer announced it had pledged $100 million to the new Antimicrobial Resistance (AMR) Action…
On Jul. 9, 2020, BioReference Laboratories, an OPKO Health company, announced that it will conduct COVID-19 testing for…
On Jul. 9, 2020, Mylan and Fujifilm Kyowa Kirin Biologics announced the FDA had approved Hulioᆴ (adalimumab-fkjp), a…
On Jul. 8, 2020, research showed that adolescents who live in areas that have high levels of artificial…
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
On Jul. 8, 2020, scientists at the UC Berkeley-UCSF Joint Medical Program reported that for some individuals with…
On Jul. 8, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…
On Jul. 8, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that it had created a registry…
On Jul. 8, 2020, the Mount Sinai Health System, Emergent BioSolutions and ImmunoTek Bio Centers announced a collaboration…
On Jul. 8, 2020, Gilead Sciences announced data evaluating the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP…
On Jul. 8, 2020, NanoViricides announced that excellent safety and tolerability of the drug candidates it is developing…
On Jul. 8, 2020, Moderna announced that it had completed enrollment for both cohorts of the Phase 2…
On Jul. 8, 2020, Constant Therapeutics reported that its peptide drug TXA127 was tested in a series of…
On Jul. 8, 2020, a Health Trendsル study from researchers at Quest Diagnostics and the University of Pittsburgh…
On Jul. 8, 2020, BD (Becton, Dickinson) announced the formation of a strategic, public-private partnership with the Biomedical…
On Jul. 8, 2020, the European Commission announced regulatory approval for the first adjuvanted quadrivalent influenza vaccine to…
On Jul. 8, 2020, the USDA announced the initial purchase of vaccine for the National Animal Vaccine and…
On Jul. 8, 2020, the Fred Hutchinson Cancer Research Center was named the coordinating center for vaccine clinical…